$253.9M
11-50
iOnctura is a biopharmaceutical company dedicated to developing innovative therapies that target the key factors contributing to immunosuppression within the tumor microenvironment. By addressing the limitations of existing immune checkpoint inhibitors, iOnctura aims to enhance treatment effectiveness for a broader range of cancer patients.
National Rank
Share
Loading...
In Switzerland
out of unicorns
Regional Rank
Share
Loading...
In Western Europe
out of unicorns
National Rank
Share
Loading...
In Switzerland
out of 0 unicorns
Regional Rank
Share
Loading...
In Western Europe
out of 9 unicorns
National Rank
Share
Loading...
In Switzerland
out of 0 unicorns
Regional Rank
Share
Loading...
In Western Europe
out of 2 unicorns
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...